OTCMKTS:BIOTU Biotech Acquisition (BIOTU) Stock Price, News & Analysis → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free BIOTU Stock Alerts $10.14 -0.84 (-7.65%) (As of 02/2/2023) Add Compare Share Share Today's Range$10.14▼$10.1750-Day Range$10.14▼$10.1452-Week Range$8.73▼$11.11Volume1,300 shsAverage Volume4,444 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Biotech Acquisition alerts: Email Address Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About Biotech Acquisition Stock (OTCMKTS:BIOTU)Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.Read More BIOTU Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BIOTU Stock News HeadlinesApril 30, 2024 | americanbankingnews.comBiotech Acquisition (OTCMKTS:BIOTU) Trading Down 7.7%April 13, 2024 | msn.comFujifilm ups US biotech plant investment by $1.2BMay 9, 2024 | Banyan Hill Publishing (Ad)The Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.March 21, 2024 | msn.comEXCLUSIVE: 2024 Witnesses Increase In Biotech Initial Public OfferingsFebruary 23, 2024 | msn.com20 Fastest Growing Biotech Companies in the USFebruary 19, 2024 | msn.comAstra Boosts Push Into China Biotech Scene With $1.2 Billion BuyFebruary 18, 2024 | finance.yahoo.comCERo Therapeutics Holdings Inc (CERO)February 7, 2024 | msn.comPhoenix Biotech Revises CERo Agreement and PIPE DealMay 9, 2024 | Banyan Hill Publishing (Ad)The Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.February 7, 2024 | msn.comPhoenix Biotech’s Strategic Unregistered Equity SaleFebruary 5, 2024 | bizjournals.comHere's what could turn around Massachusetts' biotech job market in 2024January 12, 2024 | realmoney.thestreet.com4 Biotech Stock Moves I Made Amid a Bullish Call on the SectorJanuary 8, 2024 | msn.comPhilly biotech execs find ‘optimistic vibe’ at invitation-only JPM Healthcare ConferenceJanuary 5, 2024 | msn.com3 Top Biotech Stocks Worth Adding to Your Portfolio in 2024January 4, 2024 | seekingalpha.comBiotech Bonanza: 2024 Biotech Outlook As The Fed Turns DovishJanuary 2, 2024 | msn.comGene-editing startup Tome Biosciences of Watertown snaps up a San Francisco biotechDecember 14, 2023 | msn.comWhat Has Insiders Eyeing This Biotech StockDecember 8, 2023 | msn.comBiotech Deals Are Heating Up. Why 2024 Could Be Even Hotter for M&A.November 16, 2023 | msn.comFortress Biotech GAAP EPS of -$0.94 beats by $1.83, revenue of $34.75M beats by $16MNovember 9, 2023 | msn.comAdaptive Biotech hires Goldman Sachs to explore ‘strategic alternatives’ for key business linesNovember 1, 2023 | bizjournals.comBiotech company led by former Seagen CEO picks Eastside city for new HQOctober 19, 2023 | reuters.comRisky biotech M&A therapy will heal more fracturesSeptember 27, 2023 | markets.businessinsider.com7 ‘Strong Buy’ Biotech Stocks to Rejuvenate Your PortfolioSeptember 5, 2023 | marketwatch.comPortage Biotech Shares Rise 20% After Keytruda Deal With MerckAugust 17, 2023 | msn.com7 A-Rated Biotech Stocks for Your August Buy ListJuly 27, 2023 | msn.comBharat Biotech picks up 20% stake in Eastman Exports Global ClothingJuly 21, 2023 | marketwatch.comBB Biotech 2Q Loss Narrowed; To Delist From Milan Stock ExchangeSee More Headlines Receive BIOTU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biotech Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorFinancial Services Industry Shell Companies Sub-IndustryN/A Current SymbolOTCMKTS:BIOTU CUSIPN/A CIK1825413 WebN/A PhoneN/AFaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesDr. Michael Shleifer Ph.D. (Age 49)Chairman & CEO Mr. Thomas Fratacci (Age 45)CFO & Treasurer Mr. Ivan Jarry (Age 45)Chief Operating Officer Mr. Albert F. Hummel M.B.A. (Age 77)Chief Investment Officer & Director Key Competitors99 Acquisition GroupNASDAQ:NNAGU99 Acquisition GroupNASDAQ:NNAGWA SPAC II AcquisitionNASDAQ:ASCBUA SPAC II AcquisitionNASDAQ:ASCBWAce Global Business AcquisitionNASDAQ:ACBAWView All Competitors BIOTU Stock Analysis - Frequently Asked Questions How have BIOTU shares performed in 2024? Biotech Acquisition's stock was trading at $10.14 at the start of the year. Since then, BIOTU shares have increased by 0.0% and is now trading at $10.14. View the best growth stocks for 2024 here. How do I buy shares of Biotech Acquisition? Shares of BIOTU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BIOTU) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaObama’s Forever Term [exposed]Porter & CompanyThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders348 million Americans lives to END as we know it?The Oxford ClubUrgent Nvidia WarningAltimetryRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotech Acquisition Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
